title: Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk?
authors.affiliation: Motherisk Team, Hospital for Sick Children, Toronto, Ont.
authors.forename: D
authors.initials: D
authors.lastname: Oren
authors.forename: I
authors.initials: I
authors.lastname: Nulman
authors.forename: M
authors.initials: M
authors.lastname: Makhija
authors.forename: S
authors.initials: S
authors.lastname: Ito
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D000280:Administration, Inhalation; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D015201:Meta-Analysis as Topic; D009056:Mouth Abnormalities / Q000139:chemically induced; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology* / Q000517:prevention & control*; D011261:Pregnancy Trimester, First; D018570:Risk Assessment
chemical_list: D000305:Adrenal Cortex Hormones